[柠檬酸盐治疗尿酸型肾结石]。

Urologiia i nefrologiia Pub Date : 1999-03-01

N F Sergienko, L V Shaplygin, S F Kuchits

{"title":"[柠檬酸盐治疗尿酸型肾结石]。","authors":"N F Sergienko, L V Shaplygin, S F Kuchits","doi":"","DOIUrl":null,"url":null,"abstract":"Citrate therapy was tried in 483 patients with urate nephrolithiasis. A good response was obtained both in monotherapy or in combination of urates with invasive or remote treatment. The authors advocate the drug blemaren (ESPARMA, Germany) as most beneficial among citrate drugs.","PeriodicalId":23468,"journal":{"name":"Urologiia i nefrologiia","volume":" 2","pages":"34-6"},"PeriodicalIF":0.0000,"publicationDate":"1999-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Citrate therapy in treating urate nephrolithiasis].\",\"authors\":\"N F Sergienko, L V Shaplygin, S F Kuchits\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Citrate therapy was tried in 483 patients with urate nephrolithiasis. A good response was obtained both in monotherapy or in combination of urates with invasive or remote treatment. The authors advocate the drug blemaren (ESPARMA, Germany) as most beneficial among citrate drugs.\",\"PeriodicalId\":23468,\"journal\":{\"name\":\"Urologiia i nefrologiia\",\"volume\":\" 2\",\"pages\":\"34-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urologiia i nefrologiia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologiia i nefrologiia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

对483例尿酸型肾结石患者进行了柠檬酸盐治疗。无论是单药治疗还是与侵入性或远程治疗相结合，都获得了良好的疗效。作者主张药物blemaren (ESPARMA，德国)是柠檬酸类药物中最有益的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Citrate therapy in treating urate nephrolithiasis].

Citrate therapy was tried in 483 patients with urate nephrolithiasis. A good response was obtained both in monotherapy or in combination of urates with invasive or remote treatment. The authors advocate the drug blemaren (ESPARMA, Germany) as most beneficial among citrate drugs.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Urologiia i nefrologiia

自引率

0.00%

发文量